Researchers led by Ludwig @harvard.edu’s Rakesh Jain report that dasatinib, a leukemia drug, potently inhibits the growth of a subtype of the pediatric brain cancer ependymoma (EPN) in mouse models. Dasatinib induced a complete regression of tumors of this subtype in 78% of mice. https://bit.ly/4heMuUt